arrow_back Back to App

Increased Drug Price Transparency: Patient Right to Shop Act

This new law aims to make it easier for citizens to access information about prescription drug costs. It will allow price comparison tools to function more effectively, enabling patients to make informed choices about the most affordable purchasing options, including cash prices and mail-order benefits.
Key points
Insurers and health plans cannot block access to drug price comparison tools.
Patients will receive more complete information on all drug costs, including out-of-pocket expenses and co-payments.
The act seeks to increase competition and potentially lower drug costs for citizens.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4712
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2023-07-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Patient Right to Shop Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4712.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-07-18.

What are the main provisions?

Key points include:

  • Insurers and health plans cannot block access to drug price comparison tools.
  • Patients will receive more complete information on all drug costs, including out-of-pocket expenses and co-payments.
  • The act seeks to increase competition and potentially lower drug costs for citizens.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health